Evaluation of early clinical failure criteria for gram-negative bloodstream infections

被引:22
|
作者
Rac, H. [1 ]
Gould, A. P. [2 ]
Bookstaver, P. B. [1 ,3 ]
Justo, J. A. [1 ,3 ]
Kohn, J. [3 ]
Al-Hasan, M. N. [4 ,5 ]
机构
[1] Univ South Carolina, Coll Pharm, Columbia, SC 29208 USA
[2] Novant Hlth, Charlotte, NC USA
[3] Prisma Hlth Richland, Columbia, SC USA
[4] Univ South Carolina, Sch Med, Columbia, SC 29208 USA
[5] Palmetto Hlth Univ, South Carolina Med Grp, Columbia, SC USA
关键词
Antibiotics; Bacteraemia; Bloodstream infection; Clinical failure; Early clinical failure; Enterobacteriaceae; Gram-negative infection; Treatment response; EMPIRICAL ANTIMICROBIAL THERAPY; ENTEROBACTERIACEAE BACTEREMIA; NOSOCOMIAL INFECTIONS; BETA-LACTAMS; SCORE; ADULTS; DURATION; RISK; STRATIFICATION; CEPHALOSPORINS;
D O I
10.1016/j.cmi.2019.05.017
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: The aim was the development of early clinical failure criteria (ECFC) to predict unfavourable outcomes in patients with Gram-negative bloodstream infections (GN-BSI). Methods: Adults with community-onset GN-BSI who survived hospitalization for >= 72 hr at Prisma Health-Midlands hospitals in Columbia, SC, USA from January 1, 2010 to June 30, 2015 were identified. Multivariable logistic regression was used to examine the association between clinical variables between 72 and 96 hr after GN-BSI and unfavourable outcomes (28-day mortality or hospital length of stay >14 days from GN-BSI onset). Results: Among 766 patients, 225 (29%) had unfavourable outcomes. After adjustments for Charlson Comorbidity Index and appropriateness of empirical antimicrobial therapy in multivariable model, predictors of unfavourable outcomes included systolic blood pressure <100 mmHg or vasopressor use (adjusted odds ratio (aOR) 1.8, 95% confidence interval (CI) 1.2-2.9), heart rate >100 beats/minute (aOR 1.7, 95% CI 1.1-2.5), respiratory rate >= 22 breaths/minute or mechanical ventilation (aOR 2.1, 95% CI 1.4-3.3), altered mental status (aOR 4.5, 95% CI 2.8-7.1), and white blood cell count >12 000/mm(3) (aOR 2.7, 95% CI 1.8-4.1) between 72 and 96 hr after index GN-BSI. Area under receiver operating characteristic curve of ECFC model in predicting unfavourable outcomes was 0.77 (0.84 and 0.71 in predicting 28-day mortality and prolonged hospitalization, respectively). Conclusions: Risk of 28-day mortality or prolonged hospitalization can be estimated between 72 and 96 hr after GN-BSI using ECFC. These criteria may have clinical utility in management of GN-BSI and may improve methodology of future investigations assessing response to antimicrobial therapy based on a standard evidence-based definition of early clinical failure. (c) 2019 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:73 / 77
页数:5
相关论文
共 50 条
  • [1] Gram-negative bloodstream infections
    Munoz, Patricia
    Fernandez Cruz, Ana
    Rodriguez-Creixems, Marta
    Bouza, Emilio
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2008, 32 : S10 - S14
  • [2] Clinical and Molecular Analyses of Recurrent Gram-Negative Bloodstream Infections
    Bock, Andrew
    Hanson, Blake M.
    Ruffin, Felicia
    Parsons, Joshua B.
    Park, Lawrence P.
    Sharma-Kuinkel, Batu
    Mohnasky, Michael
    Arias, Cesar A.
    Fowler, Vance G., Jr.
    Thaden, Joshua T.
    CLINICAL INFECTIOUS DISEASES, 2023, 76 (03) : E1285 - E1293
  • [3] Evaluation of clinical outcomes in patients with Gram-negative bloodstream infections according to cefepime MIC
    Rhodes, Nathaniel J.
    Liu, Jiajun
    McLaughlin, Milena M.
    Qi, Chao
    Scheetz, Marc H.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2015, 82 (02) : 165 - 171
  • [4] Cefepime effectiveness in Gram-negative bloodstream infections
    Al-Hasan, Majdi N.
    Eckel-Passow, Jeanette E.
    Baddour, Larry M.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2011, 66 (05) : 1156 - 1160
  • [5] Hemodialyzer Reuse and Gram-Negative Bloodstream Infections
    Edens, Chris
    Wong, Jacklyn
    Lyman, Meghan
    Rizzo, Kyle
    Duc Nguyen
    Blain, Michela
    Horwich-Scholefield, Sam
    Moulton-Meissner, Heather
    Epson, Erin
    Rosenberg, Jon
    Patel, Priti R.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2017, 69 (06) : 726 - 733
  • [6] Clinical and microbiological features of resistant gram-negative bloodstream infections in children
    Teke, Turkan Aydin
    Tanir, Gonul
    Bayhan, Gulsum Iclal
    Oz, Fatma Nur
    Metin, Ozge
    Ozkan, Sengul
    JOURNAL OF INFECTION AND PUBLIC HEALTH, 2017, 10 (02) : 211 - 218
  • [7] Procalcitonin as a predictor of early antibiotic treatment failure in patients with gram-negative bloodstream infections caused by urinary tract infections
    Mun, Seok Jun
    Kang, Jin Suk
    Moon, Chisook
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2021, 99 (03)
  • [8] CLINICAL AND BACTERIOLOGICAL EVALUATION OF NETILMICIN IN GRAM-NEGATIVE INFECTIONS
    KLASTERSKY, J
    CARPENTIER, FM
    KAHAN, LC
    DANEAU, D
    PREVOST, JM
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1977, 12 (04) : 503 - 509
  • [9] New evidence for managing Gram-negative bloodstream infections
    Nutman, Amir
    Tellapragada, Chaitanya
    Giske, Christian G.
    Yahav, Dafna
    CURRENT OPINION IN INFECTIOUS DISEASES, 2021, 34 (06) : 599 - 610
  • [10] The Verigene dilemma: gram-negative polymicrobial bloodstream infections and clinical decision making
    Claeys, Kimberly C.
    Heil, Emily L.
    Pogue, Jason M.
    Lephart, Paul R.
    Johnson, J. Kristie
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2018, 91 (02) : 144 - 146